Tamoxifen is used for: Breast cancer.
Recorded in the NepalDoc medicine catalog for Tamoxifen.
Metastatic Breast Cancer: Tamoxifen citrate tablets are effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, tamoxifen citrate tablets are an alternative to oophorectomy or ovarian irradiation.
From the U.S. FDA-approved label for Tamoxifen. Full label: DailyMed.
Metastatic Breast Cancer: Tamoxifen citrate tablets are effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, tamoxifen citrate tablets are an alternative to oophorectomy or ovarian irradiation. Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen citrate tablets therapy. Adjuvant Treatment of Breast Cancer: Tamoxifen citrate tablets are indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some tamoxifen citrate adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes.
From the U.S. FDA-approved label for Tamoxifen. Full label: DailyMed.
For patients with breast cancer, the recommended daily dose is 20 to 40 mg. Dosages greater than 20 mg per day should be given in divided doses (morning and evening). In three single agent adjuvant studies in women, one 10 mg tamoxifen citrate tablet was administered two (ECOG and NATO) or three (Toronto) times a day for two years.
Directions from the U.S. FDA-approved label for Tamoxifen — your doctor or pharmacist may advise differently.
Tamoxifen citrate tablets are contraindicated in patients with known hypersensitivity to the drug or any of its ingredients. Reduction in Breast Cancer Incidence in High Risk Women and Women with DCIS: Tamoxifen citrate tablets are contraindicated in women who require concomitant coumarin-type anticoagulant therapy or in women with a history of deep vein thrombosis or pulmonary embolus.
Excerpt from the U.S. FDA-approved label for Tamoxifen. Talk to a pharmacist or doctor before use.
Effects in Metastatic Breast Cancer Patients: As with other additive hormonal therapy (estrogens and androgens), hypercalcemia has been reported in some breast cancer patients with bone metastases within a few weeks of starting treatment with tamoxifen citrate. If hypercalcemia does occur, appropriate measures should be taken and, if severe, tamoxifen citrate should be discontinued. Effects on the Uterus-Endometrial Cancer and Uterine Sarcoma: An increased incidence of uterine malignancies has been reported in association with tamoxifen citrate treatment.
Warnings and precautions excerpt from the U.S. FDA-approved label for Tamoxifen — not a complete list. Talk to a pharmacist or doctor before use.
Adverse reactions to tamoxifen citrate are relatively mild and rarely severe enough to require discontinuation of treatment in breast cancer patients. Continued clinical studies have resulted in further information which better indicates the incidence of adverse reactions with tamoxifen citrate as compared to placebo.
Excerpt from the U.S. FDA-approved label for Tamoxifen — not a complete list. Talk to a pharmacist or doctor about side effects.
6 brands · 4 makers in the NepalDoc catalog — see the full Tamoxifen guide →
Store at 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label for Tamoxifen.
What is Tmoxife?
Tmoxife 10mg Tablet is a Tamoxifen medicine made by Neon Laboratories Ltd. It comes as 10mg Tablet.
What is Tmoxife used for?
Tamoxifen is used for Breast cancer.
What is the generic name of Tmoxife?
The generic name of Tmoxife is Tamoxifen.
Which brands of Tamoxifen are available in Nepal?
6 brands of Tamoxifen are listed in the NepalDoc catalog, from 4 makers — including Cytotam 10mg Tablet, Cytotam 20mg Tablet, Mamofen 10mg Tablet, Mamofen 20mg Tablet, Tamoxifen Citrate 10mg Tablet.
What are the side effects of Tamoxifen?
Adverse reactions to tamoxifen citrate are relatively mild and rarely severe enough to require discontinuation of treatment in breast cancer patients. Continued clinical studies have resulted in further information which better indicates the incidence of adverse reactions with tamoxifen citrate as compared to placebo.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
